Key points are not available for this paper at this time.
Background: Most patients with lung cancer are diagnosed with advanced disease stage, which is clinically aggressive and has high metastatic potential.FDG- PET is widely used in lung cancer staging at diagnosis, response evaluation after systemic treatment, re-staging after neo-adjuvant treatment and surveillance. To determine the diagnostic Vol. 35, No. 2, Supplementation: 156
Rawnak Afrin (Thu,) studied this question.